Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Inclusion Criteria: * male or female weighing ≥ 5kg and ≤ 25kg * P. falciparum parasitemia between 1,000 and 100,000 parasites/mm3 * with confirmed diagnosis of uncomplicated malaria caused P. falciparum parasite Exclusion Criteria: * complicated malaria * ingestion of various antimalarial drugs, or other drugs influencing cardiac function in the previous 4 weeks before study entry to 8 weeks * severe anaemia * severe malnutrition * malaria due to other than P. falciparum Other protocol-defined inclusion/exclusion criteria may apply